KGA-2727
CAS: 666842-36-0
Ref. 3D-RBB84236
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Product Information
KGA-2727 is a novel, orally administered, non-peptidic, small molecule antidiabetic agent that increases glucose uptake in skeletal muscle cells by inhibiting the sodium-dependent glucose transporter type 2 (SGLT2) and the accompanying sodium-glucose cotransporter. KGA-2727 has been shown to lower blood pressure and increase insulin sensitivity in diabetic mice. Chronic treatment with KGA-2727 has been shown to increase insulin sensitivity in wild-type mice without any adverse effects. This drug also lowers blood sugar levels in patients with type 2 diabetes.
Chemical properties
Technical inquiry about: 3D-RBB84236 KGA-2727
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.